<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Morphology</journal-id><journal-title-group><journal-title xml:lang="en">Morphology</journal-title><trans-title-group xml:lang="ru"><trans-title>Морфология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1026-3543</issn><issn publication-format="electronic">2949-2556</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">399401</article-id><article-id pub-id-type="doi">10.17816/morph.399401</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CHANGES OF THE TISSUES AND OF REGIONAL LYMPH NODES IN RATS WITH CHRONIC INFLAMMATORY PROCESS TREATED WITH INTERLEUKIN-2</article-title><trans-title-group xml:lang="ru"><trans-title>ИЗМЕНЕНИЯ ТКАНЕЙ И РЕГИОНАРНЫХ ЛИМФАТИЧЕСКИХ УЗЛОВ КРЫС ПРИ ХРОНИЧЕСКОМ ВОСПАЛИТЕЛЬНОМ ПРОЦЕССЕ В УСЛОВИЯХ ВВЕДЕНИЯ ИНТЕРЛЕЙКИНА-2</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mayborodin</surname><given-names>I V</given-names></name><name xml:lang="ru"><surname>Майбородин</surname><given-names>И В</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центр новых медицинских технологий (зав. - проф. А.И. Шевела); Институт химической биологии и фундаментальной медицины СО РАН</p></bio><email>imai@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Egorov</surname><given-names>D V</given-names></name><name xml:lang="ru"><surname>Егоров</surname><given-names>Д В</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центр новых медицинских технологий (зав. - проф. А.И. Шевела); Институт химической биологии и фундаментальной медицины СО РАН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rodisheva</surname><given-names>T M</given-names></name><name xml:lang="ru"><surname>Родишева</surname><given-names>Т М</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центр новых медицинских технологий (зав. - проф. А.И. Шевела); Институт химической биологии и фундаментальной медицины СО РАН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Strel'tsova</surname><given-names>E I</given-names></name><name xml:lang="ru"><surname>Стрельцова</surname><given-names>Е И</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центр новых медицинских технологий (зав. - проф. А.И. Шевела); Институт химической биологии и фундаментальной медицины СО РАН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shevela</surname><given-names>A I</given-names></name><name xml:lang="ru"><surname>Шевела</surname><given-names>А И</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центр новых медицинских технологий (зав. - проф. А.И. Шевела); Институт химической биологии и фундаментальной медицины СО РАН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Maiborodin</surname><given-names>I V</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Yegorov</surname><given-names>D V</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Rodisheva</surname><given-names>T M</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Streltsova</surname><given-names>E I</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Shevela</surname><given-names>A I</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Институт химической биологии и фундаментальной медицины СО РАН</institution></aff></aff-alternatives><aff id="aff2"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2011-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2011</year></pub-date><volume>139</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2011)</issue-title><issue-title xml:lang="ru">№1 (2011)</issue-title><fpage>43</fpage><lpage>48</lpage><history><date date-type="received" iso-8601-date="2023-05-09"><day>09</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, Эко-Вектор</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://j-morphology.com/1026-3543/article/view/399401">https://j-morphology.com/1026-3543/article/view/399401</self-uri><abstract xml:lang="en"><p>The structure of Wistar rat subcutaneous adipose tissue and axillary (regional) lymph nodes (LN) was studied by the methods of light microscopy after the subcutaneous implantation of the fragments of silicone mammary implant in the area of right scapula in animals treated with interleukin-2 (IL-2). Subcutaneous implantation of sterile silicone plates to rats was found to induce chronic granulomatous inflammatory process with the formation of connective tissue capsule. Implants placement to rats treated with IL-2 resulted in the formation of a thicker capsule with the signs of sclerosis, fibrosis and hyialinosis; all the capsular structures were heavily infiltrated with macrophages, which contained phagocytozed silicone fragments. After the introduction of silicone implants, the volume of the capsule and connective tissue in the regional LN progressively increased, while after IL-2 treatment the intensity of sclerotic processes was significantly decreased. The relative area of lymphoid nodules without the germinal centers in LN sections was increased 1 month following the induction of chronic inflammatory process in rats treated with IL-2, but by 6 months the proportion of nodules both with or without germinal centers become less, as compared to the initial data.</p></abstract><trans-abstract xml:lang="ru"><p>Методами световой микроскопии исследовали строение подкожной клетчатки и подмышечных (регионарных) лимфатических узлов (ЛУ) после имплантации фрагментов оболочки силиконового маммоимплантата подкожно в область правой лопатки крысам Вистар в условиях введения интерлейкина-2 (ИЛ-2). Имплантация крысам стерильных силиконовых пластинок индуцирует хронический гранулематозный воспалительный процесс и формирование соединительнотканной капсулы. После имплантации при введении ИЛ-2 формируется более толстая капсула с признаками фиброза, склероза и гиалиноза; все структуры капсулы обильно инфильтрированы макрофагами, содержащими фагоцитированные силиконовые фрагменты. После введения силиконовых имплантатов в регионарных ЛУ прогрессивно увеличивается площадь, занимаемая на срезе капсулой и соединительной тканью, после инъекции ИЛ-2 выраженность склеротических процессов значимо снижается. Относительная площадь лимфоидных узелков без герминативных центров на срезе ЛУ через 1 мес при воспалительном процессе в условиях введения ИЛ-2 возрастает, но к 6 мес доля узелков без герминативных центров и с таковыми становится меньше по сравнению с исходным показателем.</p></trans-abstract><kwd-group xml:lang="en"><kwd>subcutaneous adipose tissue</kwd><kwd>lymph nodes</kwd><kwd>silicone implant</kwd><kwd>granulomatous inflammation</kwd><kwd>interleukin-2</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>подкожная жировая ткань</kwd><kwd>лимфатический узел</kwd><kwd>силиконовый имплантат</kwd><kwd>гранулематозное воспаление</kwd><kwd>интерлейкин-2</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Добрякова О.Б. и Ковынцев Н.Н. Аугментационная маммопластика силиконовыми эндопротезами. М., МОК ЦЕНТР, 2000.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Златник Е.Ю. и Голотина Л.Ю. Применение ронколейкина для ЛАК-терапии рака яичника. Вопр. онкол., 2005, т. 51, № 6, с. 680-684.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Майбородин И.В., Гаврилова В.В., Колмакова И.А. и др. Возрастные и половые особенности тканей десны в норме и при деструктивном хроническом периодонтите. Стоматология, 2009, т. 88, № 2, с. 29-33.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Майбородин И.В., Ковынцев Н.Н. и Добрякова О.Б. Нарушения микроциркуляции как причина капсулярной контрактуры после увеличивающей маммопластики. Хирургия, 2007, № 3, с. 49-53.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Accurso A., Rocco N., Feleppa C. et al. Spread of silicone to axillary lymph nodes after high cohesive gel silicone implant rupture. Plast. Reconstr. Surg., 2008, v. 122, № 6, p. 221e-222e.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Dillman R.O. Lymphocyte therapy of renal cell carcinoma. Expert. Rev. Anticancer Ther., 2005, v. 5, № 6, p. 1041-1051.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ersek R.A. and Beisang A.A. 3rd. Bioplastique: a new textured copolymer microparticle promises permanence in soft-tissue augmentation. Plast. Reconstr. Surg., 1991, v. 87, № 4, p. 693- 702.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gayou R. and Rudolph R. Capsular contraction around silicone mammary prostheses. Ann. Plast. Sur., 1979, v. 2, № 1, p. 62-71.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hancock W.W., Kobzik L., Colby A.J. et al. Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Am. J. Pathol., 1986, v. 123, № 1, p. 1-8.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Khan U.D. Left unilateral breast autoinflation and intraprosthetic collection of sterile pus: an unusual operative finding of silicone gel bleed with silicone lymphadenitis. Aesthetic Plast. Surg., 2008, v. 32, № 4, p. 684-687.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Kjoller K., Holmich L.R., Jacobsen P.H. et al. Capsular contracture after cosmetic breast implant surgery in Denmark. Ann. Plast. Surg., 2001, v. 47, № 4, p. 359-366.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Laitung J.K., McClure J. and Shuttleworth C.A. The fibrous capsules around static and dynamic implants: their biochemical, histological, and ultrastructural characteristics. Ann. Plast. Surg., 1987, v. 19, № 3, p. 208-216.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Malek T.R., Yu A., Zhu L., Matsutani T. et al. IL-2 family of cytokines in T regulatory cell development and homeostasis. J. Clin. Immunol., 2008, v. 28, № 6, p. 635-639.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Marguti I., Yamamoto G.L., Costa da T.B. et al. Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells. Immunology, 2009, v. 127, № 1, p. 50-61.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Muramatsu Y., Sugino K., Kikuchi N. et al. Human adjuvant disease which developed after silicone augmentation mammoplasty. Nihon Kokyuki Gakkai Zasshi, 2009, v. 47, № 3, p. 237-241.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Pierce V.E. Jr., Pantazis C.G. and Ades E.W. Examination of differentiation, proliferation and distribution of lymphoid cells in mice by immunohistochemical analysis post in vivo administration of recombinant interleukin-II. J. Clin. Lab. Immunol., 1988, v. 25, № 1, p. 47-52.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Piguet P.F., Grau G., Irle C. and Vassalli P. Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells. Eur. J. Immunol., 1986, v. 16, № 10, p. 1257-1261.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Poudrier J. and Owens T. Th1 and Th2 help for B cells: differential capacity for induction of autonomous responsiveness to IL-2. Int. Immunol., 1995, v. 7, № 6, p. 1021-1027.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Spieker-Polet H., Yam P.C., Arbieva Z. et al. In vitro induction of the expression of multiple IgA isotype genes in rabbit B cells by TGF-beta and IL-2. J. Immunol., 1999, v. 162, № 9, p. 5380-5388.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Wang Z.H., Zhu J.Y., Li T. and Leng X.S. Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro. Zhonghua Yi Xue Za Zhi, 2008, v. 88, № 12, p. 844-847.</mixed-citation></ref></ref-list></back></article>
